Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Shanghai Mental Health Center (Shanghai Psychological Counselling Training Center) is navigating 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units, showing a split in the prosecution workload. This distribution indicates that the center is pursuing multiple distinct innovations within the biotech field. For a practitioner, this variety is beneficial as it prevents the entire portfolio's progress from being dependent on a single examiner's perspective or the specific practices of one art unit.
WEIDNER, ADAM M is the busiest examiner, with 1 busiest examiner pending action. This represents one of the 2 pending office actions total, with the other action being handled by the second of the 2 distinct examiners assigned to the portfolio. This balanced distribution of the 2 pending office actions across different examiners and art units suggests a diversified approach to securing intellectual property. Each action can be managed independently, allowing the center to tailor its prosecution tactics to the specific requirements and feedback of each individual examiner involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WEIDNER, ADAM M | 1 | 63.7% | +33.6% |
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279961 | APPLICATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 IN PREPARATION OF DRUGS FOR RESISTING MENTAL DISORDERS CAUSED BY EARLY LIFE STRESS | KATAKAM, SUDHAKAR | 23d overdue |
| 18579591 | USE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2 IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF NEUROLOGICAL DEMYELINATING DISEASES | WEIDNER, ADAM M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279961 | APPLICATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 IN PREPARATION OF DRUGS FOR RESISTING MENTAL DISORDERS CAUSED BY EARLY LIFE STRESS | KATAKAM, SUDHAKAR | 23d overdue |
| 18579591 | USE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2 IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF NEUROLOGICAL DEMYELINATING DISEASES | WEIDNER, ADAM M | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18579591 | USE OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2 IN THE PREPARATION OF DRUGS FOR THE TREATMENT OF NEUROLOGICAL DEMYELINATING DISEASES | WEIDNER, ADAM M | 1675 | §101§102§112DP | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18279961 | APPLICATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 2 IN PREPARATION OF DRUGS FOR RESISTING MENTAL DISORDERS CAUSED BY EARLY LIFE STRESS | KATAKAM, SUDHAKAR | 1658 | §101§102Other | Non-Final OA | 23d overdue | Pending | Sep 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShanghai Mental Health Center (Shanghai Psychological Counselling Training Center) has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Adam M Weidner has the most, with 1 of Shanghai Mental Health Center (Shanghai Psychological Counselling Training Center)'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
